Literature DB >> 29576598

Clinical Characteristics, Management, and Outcomes of Japanese Patients Hospitalized for Heart Failure With Preserved Ejection Fraction - A Report From the Japanese Heart Failure Syndrome With Preserved Ejection Fraction (JASPER) Registry.

Toshiyuki Nagai1,2,3, Tsutomu Yoshikawa4, Yoshihiko Saito5, Yasuchika Takeishi6, Kazuhiro Yamamoto7, Hisao Ogawa1, Toshihisa Anzai1,3.   

Abstract

BACKGROUND: Despite the specific characteristics of heart failure with preserved ejection fraction (HFpEF) having been demonstrated predominantly from registries in Western countries, important international differences exist in terms of patient characteristics, management and medical infrastructure between Western and Asian countries.Methods and 
Results: We performed nationwide registration of consecutive Japanese hospitalized HFpEF patients with left ventricular EF ≥50% from 15 sites between November 2012 and March 2015. Follow-up data were obtained up to 2 years post-discharge. A total of 535 patients were registered. The median age was 80 years and 50% were female. The most common comorbid conditions were hypertension (77%) and atrial fibrillation (AF: 62%), but body mass index was relatively low. In-hospital mortality rate was 1.3% and the median length of hospitalization was 16 days. By 2 years post-discharge, 40.8% of patients had all-cause death or HF hospitalization. Approximately one-half of deaths had a cardiac cause. Lower serum albumin on admission was one of the strongest independent determinants of worse clinical outcome.
CONCLUSIONS: Japanese HFpEF patients were less obese, but had a substantially higher prevalence of AF and lower incidence of subsequent events compared with previous reports. Our findings indicated that specific preventative and therapeutic strategies focusing on AF and nutritional status might need to be considered for Japanese hospitalized patients with HFpEF.

Entities:  

Keywords:  Albumin; Epidemiology; Heart failure with preserved ejection fraction; Japan; Prognosis

Mesh:

Substances:

Year:  2018        PMID: 29576598     DOI: 10.1253/circj.CJ-18-0073

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  17 in total

1.  Effect of Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Hufang Zhou; Wenhua Peng; Fuyao Li; Yuelin Wang; Baofu Wang; Yukun Ding; Qian Lin; Ying Zhao; Guozhong Pan; Xian Wang
Journal:  Front Cardiovasc Med       Date:  2022-05-04

2.  Predictors of activities of daily living at discharge in elderly patients with heart failure with preserved ejection fraction.

Authors:  Masahiro Kitamura; Kazuhiro P Izawa; Kodai Ishihara; Masakazu Yaekura; Hitomi Nagashima; Takashi Yoshizawa; Nobuhiro Okamoto
Journal:  Heart Vessels       Date:  2020-10-29       Impact factor: 2.037

3.  Trimethylamine N-oxide and outcomes in patients hospitalized with acute heart failure and preserved ejection fraction.

Authors:  Yoshiharu Kinugasa; Kensuke Nakamura; Hiroko Kamitani; Masayuki Hirai; Kiyotaka Yanagihara; Masahiko Kato; Kazuhiro Yamamoto
Journal:  ESC Heart Fail       Date:  2021-03-18

4.  Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: A meta-analysis.

Authors:  Gaoyang Gu; Jing Wu; Xiaofei Gao; Meijun Liu; Chaolun Jin; Yizhou Xu
Journal:  Clin Cardiol       Date:  2022-05-11       Impact factor: 3.287

5.  Malnutrition in acute heart failure with preserved ejection fraction: clinical correlates and prognostic implications.

Authors:  Shih-Chieh Chien; Chi-In Lo; Chao-Feng Lin; Kuo-Tzu Sung; Jui-Peng Tsai; Wen-Hung Huang; Chun-Ho Yun; Ta-Chuan Hung; Jiun-Lu Lin; Chia-Yuan Liu; Charles Jia-Yin Hou; I-Hsien Tsai; Cheng-Huang Su; Hung-I Yeh; Chung-Lieh Hung
Journal:  ESC Heart Fail       Date:  2019-08-10

6.  Left ventricular outflow tract velocity time integral in hospitalized heart failure with preserved ejection fraction.

Authors:  Kazunori Omote; Toshiyuki Nagai; Hiroyuki Iwano; Shingo Tsujinaga; Kiwamu Kamiya; Tadao Aikawa; Takao Konishi; Takuma Sato; Yoshiya Kato; Hirokazu Komoriyama; Yuta Kobayashi; Kazuhiro Yamamoto; Tsutomu Yoshikawa; Yoshihiko Saito; Toshihisa Anzai
Journal:  ESC Heart Fail       Date:  2019-12-18

7.  Anemia has an impact on prognosis in heart failure with preserved ejection fraction with mild chronic kidney disease.

Authors:  Keisuke Okuno; Yoshiro Naito; Masanori Asakura; Masataka Sugahara; Tetsuo Horimatsu; Seiki Yasumura; Saki Tahara; Toshiyuki Nagai; Yoshihiko Saito; Tsutomu Yoshikawa; Tohru Masuyama; Masaharu Ishihara; Toshihisa Anzai
Journal:  Int J Cardiol Heart Vasc       Date:  2021-05-20

8.  TMAO, a seafood-derived molecule, produces diuresis and reduces mortality in heart failure rats.

Authors:  Marta Gawrys-Kopczynska; Marek Konop; Klaudia Maksymiuk; Katarzyna Kraszewska; Ladislav Derzsi; Krzysztof Sozanski; Robert Holyst; Marta Pilz; Emilia Samborowska; Leszek Dobrowolski; Kinga Jaworska; Izabella Mogilnicka; Marcin Ufnal
Journal:  Elife       Date:  2020-06-08       Impact factor: 8.140

9.  Geriatric nutritional risk index predicts all-cause deaths in heart failure with preserved ejection fraction.

Authors:  Isao Nishi; Yoshihiro Seo; Yoshie Hamada-Harimura; Masayoshi Yamamoto; Tomoko Ishizu; Akinori Sugano; Kimi Sato; Seika Sai; Kenichi Obara; Shoji Suzuki; Akira Koike; Kazutaka Aonuma; Masaki Ieda
Journal:  ESC Heart Fail       Date:  2019-02-01

10.  H2 FPEF score for predicting future heart failure in stable outpatients with cardiovascular risk factors.

Authors:  Satoru Suzuki; Koichi Kaikita; Eiichiro Yamamoto; Daisuke Sueta; Masahiro Yamamoto; Masanobu Ishii; Miwa Ito; Koichiro Fujisue; Hisanori Kanazawa; Satoshi Araki; Yuichiro Arima; Seiji Takashio; Hiroki Usuku; Taishi Nakamura; Kenji Sakamoto; Yasuhiro Izumiya; Hirofumi Soejima; Hiroaki Kawano; Hideaki Jinnouchi; Kunihiko Matsui; Kenichi Tsujita
Journal:  ESC Heart Fail       Date:  2020-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.